Posted on 7월 27, 20227/27/22
Commercialization Strategies in Oncology — The Right Partner Can Reduce Risk and Boost Rewards
Posted on 7월 13, 20227/13/22
In the Emerging World of Prescription Digital Therapeutics (PDTs), Can You Really be Prescriptive?
Posted on 6월 29, 20226/29/22
An Innovative Approach to Comprehensive Key Opinion Leader (KOL) Mapping
Posted on 6월 1, 20226/1/22
New Medicines, New Access, New Frontiers
Posted on 6월 1, 20226/1/22
KAM Reimagined: Building a Strategic Framework to Empower Key Account Management
Posted on 5월 24, 20225/24/22
Overcome In-Licensing Barriers to Increase Throughput of Assets
Posted on 5월 13, 20225/13/22
Is Your Digital Communication Strategy Up to Par?
Posted on 4월 14, 20224/14/22
Impact of Patient Reported Outcome Measures on HTA Decisions for Rare Diseases
Posted on 4월 8, 20224/8/22
EVERSANA Featured in NIH Study Detailing the Cost of Treating Rare Disease
Posted on 4월 6, 20224/6/22